LABETALOL

LABETALOL was reported 13483 times

LABETALOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ULTRASOUND ANTENATAL SCREEN 46 0.4792
1 ZOONOTIC BACTERIAL INFECTION 14 0.4242
2 SUPERIMPOSED PRE-ECLAMPSIA 10 0.2857
3 TRIGEMINO-CARDIAC REFLEX 17 0.2099
4 NEUTROPENIA NEONATAL 30 0.1345
5 TRISOMY 18 44 0.1155
6 CONGENITAL TERATOMA 9 0.1047
7 PHAEOCHROMOCYTOMA CRISIS 18 0.0849
8 HYDROPS FOETALIS 50 0.0816
9 DANDY-WALKER SYNDROME 21 0.0811
10 VENTRICULAR ASYSTOLE 14 0.0805
11 WITHDRAWAL HYPERTENSION 16 0.0792
12 MULTIPLE DRUG THERAPY 55 0.0729
13 MYCOBACTERIUM MARINUM INFECTION 18 0.0554
14 FOETAL DISORDER 45 0.0538
15 LOW BIRTH WEIGHT BABY 418 0.0526
16 ECLAMPSIA 19 0.0518
17 MACROCEPHALY 20 0.0515
18 PRE-ECLAMPSIA 241 0.0507
19 ATRIOVENTRICULAR SEPTAL DEFECT 22 0.0468
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 48 0.0452
21 POLYDACTYLY 51 0.0440
22 HYPERMAGNESAEMIA 28 0.0429
23 CLEFT LIP AND PALATE 46 0.0411
24 NEPHROGENIC ANAEMIA 189 0.0408
25 HYPERPARATHYROIDISM SECONDARY 90 0.0359
26 MATERNAL EXPOSURE DURING DELIVERY 35 0.0353
27 PREMATURE DELIVERY 516 0.0324
28 HELLP SYNDROME 19 0.0310
29 EXOMPHALOS 16 0.0298
30 NEURODEVELOPMENTAL DISORDER 20 0.0296
31 ACCELERATED HYPERTENSION 11 0.0290
32 PHAEOCHROMOCYTOMA 19 0.0288
33 HYPERTENSIVE ENCEPHALOPATHY 17 0.0286
34 INSULIN AUTOIMMUNE SYNDROME 10 0.0280
35 HYPERALDOSTERONISM 9 0.0261
36 GESTATIONAL HYPERTENSION 33 0.0255
37 FOETAL HEART RATE DECELERATION ABNORMALITY 18 0.0255
38 CHOREOATHETOSIS 17 0.0250
39 PREMATURE BABY 752 0.0250
40 NEONATAL HYPOXIA 19 0.0230
41 FOETAL GROWTH RESTRICTION 136 0.0223
42 END STAGE RENAL DISEASE 381 0.0209
43 PLACENTAL INSUFFICIENCY 16 0.0199
44 ENDOMETRITIS 13 0.0195
45 HYPERTENSIVE EMERGENCY 23 0.0195
46 FOETAL EXPOSURE DURING DELIVERY 13 0.0192
47 TRISOMY 21 24 0.0190
48 OLIGOHYDRAMNIOS 63 0.0189
49 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 20 0.0185
50 INDUCED LABOUR 11 0.0184
51 NEONATAL RESPIRATORY DISTRESS 17 0.0180
52 BRASH SYNDROME 25 0.0178
53 BLOOD PRESSURE INADEQUATELY CONTROLLED 107 0.0178
54 BREECH PRESENTATION 22 0.0175
55 HAEMORRHAGIC TRANSFORMATION STROKE 25 0.0166
56 APGAR SCORE LOW 21 0.0163
57 MALIGNANT HYPERTENSION 13 0.0151
58 FOETAL DISTRESS SYNDROME 31 0.0146
59 EXERCISE TOLERANCE DECREASED 84 0.0146
60 REBOUND ACID HYPERSECRETION 44 0.0145
61 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 23 0.0143
62 C-REACTIVE PROTEIN DECREASED 9 0.0138
63 BRONCHOPULMONARY DYSPLASIA 11 0.0137
64 HYPOGLYCAEMIA NEONATAL 21 0.0130
65 FOETAL HEART RATE ABNORMAL 12 0.0130
66 TRANSPOSITION OF THE GREAT VESSELS 10 0.0128
67 GENE MUTATION 25 0.0126
68 MULTIPLE CONGENITAL ABNORMALITIES 18 0.0125
69 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 10 0.0123
70 FOETAL EXPOSURE DURING PREGNANCY 976 0.0120
71 LIVE BIRTH 100 0.0119
72 TWIN PREGNANCY 10 0.0119
73 CAESAREAN SECTION 138 0.0118
74 LABILE BLOOD PRESSURE 14 0.0118
75 FOETAL GROWTH RETARDATION 9 0.0115
76 MATERNAL EXPOSURE DURING PREGNANCY 1001 0.0112
77 POSTPARTUM HAEMORRHAGE 15 0.0111
78 ANAEMIA OF CHRONIC DISEASE 10 0.0111
79 HYPOTONIA NEONATAL 17 0.0109
80 BRADYCARDIA FOETAL 9 0.0108
81 EXPOSURE DURING PREGNANCY 672 0.0108
82 LICHEN PLANUS 25 0.0108
83 FOETAL DEATH 55 0.0106
84 PREMATURE LABOUR 54 0.0095
85 NEONATAL RESPIRATORY DISTRESS SYNDROME 33 0.0093
86 EXPOSURE VIA BREAST MILK 37 0.0093
87 PREMATURE SEPARATION OF PLACENTA 14 0.0091
88 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 85 0.0089
89 HYPOSPADIAS 18 0.0086
90 CHRONIC KIDNEY DISEASE 646 0.0085
91 NEPHROGENIC SYSTEMIC FIBROSIS 25 0.0083
92 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 9 0.0080
93 SPEECH DISORDER DEVELOPMENTAL 23 0.0080
94 METABOLIC SURGERY 9 0.0079
95 NORMAL NEWBORN 43 0.0079
96 DEATH NEONATAL 11 0.0079
97 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 14 0.0079
98 SMALL FOR DATES BABY 38 0.0076
99 BLOOD CHLORIDE INCREASED 13 0.0075
100 RENAL ARTERY STENOSIS 10 0.0073
101 INTRAVENTRICULAR HAEMORRHAGE 18 0.0072
102 HYPERTROPHIC CARDIOMYOPATHY 11 0.0071
103 HYPERPHOSPHATAEMIA 15 0.0070
104 PULSELESS ELECTRICAL ACTIVITY 28 0.0067
105 HYPERTENSIVE CRISIS 73 0.0066
106 DIABETES MELLITUS INADEQUATE CONTROL 116 0.0065
107 MEAN CELL VOLUME DECREASED 10 0.0065
108 NIPPLE PAIN 13 0.0064
109 RENAL TUBULAR NECROSIS 62 0.0063
110 PATENT DUCTUS ARTERIOSUS 25 0.0063
111 STILLBIRTH 30 0.0062
112 ENTEROBACTER INFECTION 10 0.0059
113 GESTATIONAL DIABETES 28 0.0059
114 ATTENTION DEFICIT HYPERACTIVITY DISORDER 24 0.0057
115 MATERNAL EXPOSURE DURING BREAST FEEDING 23 0.0057
116 RENAL INJURY 168 0.0056
117 SUPRAVENTRICULAR EXTRASYSTOLES 19 0.0056
118 VENTRICULAR HYPERTROPHY 14 0.0056
119 ATRIOVENTRICULAR BLOCK FIRST DEGREE 24 0.0055
120 ANGLE CLOSURE GLAUCOMA 14 0.0055
121 TETANY 10 0.0055
122 STENOSIS 10 0.0053
123 COMPLICATIONS OF TRANSPLANTED KIDNEY 12 0.0053
124 JAUNDICE NEONATAL 10 0.0053
125 MATERNAL EXPOSURE BEFORE PREGNANCY 36 0.0053
126 POTENTIATING DRUG INTERACTION 17 0.0051
127 PREMATURE RUPTURE OF MEMBRANES 12 0.0050
128 HYPERTENSIVE HEART DISEASE 9 0.0048
129 RESPIRATORY RATE DECREASED 15 0.0048
130 AZOTAEMIA 19 0.0048
131 RENAL TRANSPLANT 17 0.0047
132 DRUG SCREEN FALSE POSITIVE 13 0.0047
133 DISSEMINATED TUBERCULOSIS 12 0.0047
134 MATERNAL DRUGS AFFECTING FOETUS 35 0.0046
135 DIASTOLIC DYSFUNCTION 14 0.0045
136 SUSPECTED SUICIDE 21 0.0045
137 COMPUTERISED TOMOGRAM ABNORMAL 10 0.0044
138 RENAL FAILURE 581 0.0044
139 HAEMOLYTIC URAEMIC SYNDROME 10 0.0043
140 AORTIC ARTERIOSCLEROSIS 11 0.0043
141 MATERNAL EXPOSURE TIMING UNSPECIFIED 16 0.0043
142 ACUTE KIDNEY INJURY 645 0.0042
143 PROTEINURIA 80 0.0042
144 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 10 0.0040
145 PREGNANCY 81 0.0040
146 RENAL FAILURE CHRONIC 31 0.0040
147 CAROTID ARTERY STENOSIS 14 0.0040
148 THROMBOSIS IN DEVICE 13 0.0040
149 ENDOTRACHEAL INTUBATION 11 0.0039
150 SKIN HYPERTROPHY 11 0.0039
151 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
152 NEPHROPATHY 36 0.0039
153 IRON DEFICIENCY 17 0.0038
154 KIDNEY TRANSPLANT REJECTION 18 0.0037
155 ACUTE PULMONARY OEDEMA 21 0.0037
156 TORSADE DE POINTES 29 0.0037
157 TONGUE OEDEMA 14 0.0037
158 AORTIC DISSECTION 15 0.0036
159 HYPERTENSION 767 0.0036
160 SINUS BRADYCARDIA 35 0.0036
161 RALES 21 0.0036
162 CYTOMEGALOVIRUS VIRAEMIA 16 0.0036
163 HAEMODYNAMIC INSTABILITY 27 0.0035
164 HYPERKALAEMIA 119 0.0034
165 THROMBOTIC MICROANGIOPATHY 33 0.0034
166 BLOOD MAGNESIUM DECREASED 29 0.0034
167 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
168 ANHEDONIA 87 0.0033
169 HYDROCEPHALUS 18 0.0033
170 HEPATIC CYTOLYSIS 42 0.0033
171 MENTAL STATUS CHANGES 90 0.0032
172 HYPERVOLAEMIA 16 0.0032
173 WRONG PRODUCT ADMINISTERED 21 0.0031
174 BRAIN INJURY 31 0.0031
175 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
176 EXPOSURE DURING BREAST FEEDING 10 0.0030
177 TRANSPLANT REJECTION 24 0.0030
178 ABORTION SPONTANEOUS 120 0.0030
179 BRADYCARDIA 157 0.0030
180 HAEMORRHAGE INTRACRANIAL 44 0.0029
181 CARDIOMEGALY 36 0.0029
182 REGURGITATION 10 0.0029
183 FAILURE TO THRIVE 15 0.0029
184 NASAL DRYNESS 18 0.0029
185 BUNDLE BRANCH BLOCK LEFT 12 0.0028
186 FACIAL PARESIS 10 0.0028
187 HYPERNATRAEMIA 14 0.0028
188 RESPIRATORY ACIDOSIS 11 0.0028
189 HEPATIC NEOPLASM 9 0.0028
190 CAROTID ARTERY OCCLUSION 10 0.0027
191 PULSE ABSENT 13 0.0027
192 HAEMORRHAGIC ANAEMIA 12 0.0027
193 BLOOD CREATINE INCREASED 12 0.0027
194 HAEMORRHAGIC STROKE 21 0.0027
195 FLUID OVERLOAD 39 0.0027
196 PULMONARY OEDEMA 120 0.0027
197 DIALYSIS 38 0.0027
198 CARDIAC MURMUR 23 0.0027
199 SNORING 10 0.0026
200 TRICUSPID VALVE INCOMPETENCE 21 0.0026
201 HYPOCALCAEMIA 50 0.0026
202 CARDIOMYOPATHY 39 0.0026
203 BLOOD PRESSURE SYSTOLIC DECREASED 12 0.0026
204 HALLUCINATIONS, MIXED 11 0.0026
205 ATELECTASIS 25 0.0026
206 HYPOMAGNESAEMIA 36 0.0026
207 AORTIC STENOSIS 9 0.0026
208 BLOOD PRESSURE FLUCTUATION 62 0.0026
209 ECONOMIC PROBLEM 39 0.0026
210 HYPOALBUMINAEMIA 20 0.0026
211 PROSTATOMEGALY 10 0.0025
212 PULMONARY HYPERTENSION 53 0.0025
213 BLOOD PRESSURE INCREASED 389 0.0025
214 ORTHOSTATIC HYPOTENSION 44 0.0025
215 SLEEP APNOEA SYNDROME 48 0.0025
216 STATUS EPILEPTICUS 28 0.0025
217 INGUINAL HERNIA 15 0.0025
218 BRAIN OEDEMA 31 0.0025
219 VENTRICULAR SEPTAL DEFECT 14 0.0024
220 ATAXIA 29 0.0024
221 ABORTION INDUCED 23 0.0024
222 CARDIAC ARREST 201 0.0024
223 RESPIRATORY DISTRESS 67 0.0024
224 OLIGURIA 15 0.0024
225 ANEURYSM 12 0.0024
226 GINGIVITIS 13 0.0024
227 ISCHAEMIA 11 0.0024
228 LEFT VENTRICULAR DYSFUNCTION 16 0.0024
229 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
230 LUNG INFILTRATION 21 0.0024
231 PSEUDOMONAS INFECTION 20 0.0023
232 HEPATITIS ACUTE 15 0.0023
233 ACUTE RESPIRATORY FAILURE 44 0.0023
234 ENTEROCOCCAL INFECTION 11 0.0023
235 ATRIAL SEPTAL DEFECT 19 0.0023
236 RENAL CYST 18 0.0023
237 CEREBRAL ATROPHY 9 0.0023
238 HYPOVOLAEMIA 13 0.0022
239 BLOOD POTASSIUM INCREASED 36 0.0022
240 BLOOD CREATININE INCREASED 144 0.0022
241 AUTOIMMUNE HEPATITIS 15 0.0022
242 CARDIAC FAILURE CONGESTIVE 173 0.0022
243 PERIPHERAL VASCULAR DISORDER 11 0.0021
244 VENTRICULAR TACHYCARDIA 35 0.0021
245 CORONARY ARTERY DISEASE 64 0.0021
246 BLOOD PRESSURE ABNORMAL 42 0.0021
247 APLASTIC ANAEMIA 11 0.0021
248 CARDIAC VALVE DISEASE 12 0.0021
249 HYPERLIPIDAEMIA 25 0.0021
250 CARDIOGENIC SHOCK 30 0.0021
251 FREQUENT BOWEL MOVEMENTS 56 0.0021
252 HAEMOLYSIS 16 0.0021
253 VENTRICULAR FIBRILLATION 23 0.0021
254 MEDICATION ERROR 115 0.0021
255 UPPER-AIRWAY COUGH SYNDROME 17 0.0021
256 TACHYPNOEA 28 0.0021
257 COGNITIVE DISORDER 96 0.0021
258 APNOEA 16 0.0021
259 RENAL CELL CARCINOMA 10 0.0020
260 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
261 MITRAL VALVE INCOMPETENCE 23 0.0020
262 RESPIRATION ABNORMAL 14 0.0020
263 COMPLETED SUICIDE 169 0.0020
264 STAPHYLOCOCCAL SEPSIS 10 0.0020
265 HAEMODIALYSIS 17 0.0020
266 ARTERIOSCLEROSIS 19 0.0020
267 METABOLIC ACIDOSIS 64 0.0020
268 BLOOD POTASSIUM DECREASED 60 0.0020
269 PERITONITIS BACTERIAL 20 0.0020
270 UNRESPONSIVE TO STIMULI 51 0.0020
271 ANURIA 17 0.0020
272 HYPOKALAEMIA 91 0.0020
273 SUBARACHNOID HAEMORRHAGE 20 0.0020
274 IRON DEFICIENCY ANAEMIA 18 0.0019
275 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
276 URINE OUTPUT DECREASED 17 0.0019
277 DRUG-INDUCED LIVER INJURY 61 0.0019
278 HYPERCALCAEMIA 24 0.0019
279 RENAL IMPAIRMENT 162 0.0019
280 BLOOD URIC ACID INCREASED 11 0.0019
281 HYPOXIA 67 0.0019
282 TREATMENT NONCOMPLIANCE 104 0.0019
283 BLOOD LACTIC ACID INCREASED 10 0.0019
284 TRANSAMINASES INCREASED 42 0.0019
285 NEUROTOXICITY 33 0.0019
286 PULMONARY MASS 28 0.0019
287 LARGE INTESTINE POLYP 13 0.0019
288 EXTRASYSTOLES 13 0.0019
289 GENERALISED OEDEMA 23 0.0019
290 HEART RATE DECREASED 65 0.0018
291 TROPONIN INCREASED 14 0.0018
292 GOUT 33 0.0018
293 HYPOTENSION 368 0.0018
294 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0018
295 INTESTINAL ISCHAEMIA 10 0.0018
296 OEDEMA PERIPHERAL 221 0.0018
297 RESPIRATORY FAILURE 132 0.0018
298 HEMIPLEGIA 15 0.0018
299 HYPOTONIA 18 0.0018
300 CEREBRAL INFARCTION 44 0.0018
301 POST-TRAUMATIC STRESS DISORDER 12 0.0018
302 CEREBRAL HAEMORRHAGE 64 0.0018
303 HAEMOLYTIC ANAEMIA 16 0.0018
304 PERICARDIAL EFFUSION 41 0.0018
305 UTERINE PERFORATION 15 0.0018
306 MOBILITY DECREASED 126 0.0018
307 HYPOGLYCAEMIA 85 0.0018
308 ENCEPHALOPATHY 43 0.0017
309 CONTRAINDICATED PRODUCT ADMINISTERED 53 0.0017
310 MIOSIS 14 0.0017
311 ALANINE AMINOTRANSFERASE INCREASED 107 0.0017
312 PLEURAL EFFUSION 106 0.0017
313 PSYCHOLOGICAL TRAUMA 15 0.0017
314 PARAESTHESIA ORAL 25 0.0017
315 DEPRESSED MOOD 91 0.0017
316 SEROTONIN SYNDROME 33 0.0017
317 FLANK PAIN 16 0.0017
318 CONTUSION 164 0.0017
319 STAPHYLOCOCCAL INFECTION 56 0.0017
320 INTESTINAL PERFORATION 19 0.0017
321 ANGINA UNSTABLE 11 0.0017
322 CONGENITAL ANOMALY 13 0.0017
323 PREGNANCY WITH CONTRACEPTIVE DEVICE 15 0.0017
324 CENTRAL NERVOUS SYSTEM LESION 23 0.0017
325 MOTOR DYSFUNCTION 17 0.0017
326 APPETITE DISORDER 11 0.0017
327 LUPUS-LIKE SYNDROME 15 0.0017
328 BLOOD GLUCOSE FLUCTUATION 18 0.0016
329 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 42 0.0016
330 TRANSIENT ISCHAEMIC ATTACK 55 0.0016
331 RENAL FAILURE ACUTE 69 0.0016
332 THERAPY NON-RESPONDER 73 0.0016
333 PERIPHERAL SWELLING 249 0.0016
334 HAIR COLOUR CHANGES 20 0.0016
335 INFUSION SITE EXTRAVASATION 10 0.0016
336 PRESCRIBED OVERDOSE 31 0.0016
337 INFUSION SITE SWELLING 10 0.0016
338 CHOLECYSTITIS ACUTE 9 0.0016
339 HAEMATOMA 41 0.0016
340 OBESITY 25 0.0016
341 AMNESIA 102 0.0016
342 BOWEL MOVEMENT IRREGULARITY 12 0.0016
343 DEVICE RELATED INFECTION 24 0.0016
344 MULTIPLE ORGAN DYSFUNCTION SYNDROME 44 0.0016
345 HAND FRACTURE 11 0.0016
346 POOR QUALITY DRUG ADMINISTERED 10 0.0015
347 INFUSION SITE ERYTHEMA 13 0.0015
348 VITAMIN D DEFICIENCY 15 0.0015
349 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
350 ACUTE MYOCARDIAL INFARCTION 45 0.0015
351 BODY TEMPERATURE DECREASED 15 0.0015
352 MALNUTRITION 17 0.0015
353 RENAL PAIN 16 0.0015
354 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
355 EYE HAEMORRHAGE 20 0.0015
356 HYPOPHOSPHATAEMIA 11 0.0015
357 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
358 DYSARTHRIA 56 0.0015
359 BRONCHIECTASIS 10 0.0015
360 SPINAL OSTEOARTHRITIS 13 0.0015
361 HAEMATOCRIT DECREASED 29 0.0015
362 ECCHYMOSIS 10 0.0015
363 SPLENOMEGALY 17 0.0014
364 LYMPHOEDEMA 10 0.0014
365 AORTIC ANEURYSM 11 0.0014
366 LEUKOCYTOSIS 26 0.0014
367 BLOOD UREA INCREASED 24 0.0014
368 CANDIDA INFECTION 24 0.0014
369 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 11 0.0014
370 BODY HEIGHT DECREASED 15 0.0014
371 INCOHERENT 9 0.0014
372 CORONARY ARTERY OCCLUSION 19 0.0014
373 GASTROENTERITIS VIRAL 25 0.0014
374 MUSCLE SPASTICITY 17 0.0014
375 DRUG EXPOSURE DURING PREGNANCY 47 0.0014
376 SMALL INTESTINAL OBSTRUCTION 17 0.0014
377 COAGULOPATHY 23 0.0014
378 GASTROOESOPHAGEAL REFLUX DISEASE 111 0.0014
379 NEUTROPHIL COUNT INCREASED 14 0.0014
380 PULMONARY CONGESTION 18 0.0014
381 MOUTH HAEMORRHAGE 10 0.0014
382 APHONIA 19 0.0014
383 TOOTH FRACTURE 15 0.0014
384 COVID-19 PNEUMONIA 16 0.0014
385 PERITONITIS 28 0.0014
386 CEREBRAL DISORDER 10 0.0014
387 CHOLECYSTITIS CHRONIC 9 0.0013
388 HYDRONEPHROSIS 10 0.0013
389 HAIR DISORDER 11 0.0013
390 CEREBROVASCULAR ACCIDENT 225 0.0013
391 BLOOD SODIUM DECREASED 25 0.0013
392 VITREOUS FLOATERS 13 0.0013
393 FLUID RETENTION 67 0.0013
394 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
395 UROSEPSIS 12 0.0013
396 BACK DISORDER 21 0.0013
397 MASS 18 0.0013
398 PELVIC FRACTURE 10 0.0013
399 WOUND INFECTION 14 0.0013
400 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
401 DRUG INTERACTION 202 0.0013
402 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
403 DIVERTICULUM 9 0.0013
404 SPUTUM DISCOLOURED 12 0.0013
405 BLOOD IRON DECREASED 15 0.0013
406 SINUS DISORDER 25 0.0013
407 BLOOD ALBUMIN DECREASED 10 0.0013
408 HYPERBILIRUBINAEMIA 13 0.0013
409 VENTRICULAR EXTRASYSTOLES 13 0.0013
410 IMPAIRED GASTRIC EMPTYING 17 0.0012
411 INTENTIONAL PRODUCT USE ISSUE 109 0.0012
412 DIZZINESS POSTURAL 12 0.0012
413 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
414 CARDIOTOXICITY 11 0.0012
415 TASTE DISORDER 25 0.0012
416 ANKLE FRACTURE 19 0.0012
417 FEAR 33 0.0012
418 ANAL INCONTINENCE 11 0.0012
419 NEPHROLITHIASIS 56 0.0012
420 DEVELOPMENTAL DELAY 11 0.0012
421 OEDEMA 66 0.0012
422 ESCHERICHIA INFECTION 10 0.0012
423 MULTI-ORGAN FAILURE 21 0.0012
424 ARTHROPOD BITE 9 0.0012
425 INJURY 85 0.0012
426 ILEUS 15 0.0012
427 MADAROSIS 14 0.0012
428 DECREASED ACTIVITY 13 0.0012
429 CYTOMEGALOVIRUS INFECTION 20 0.0012
430 SEASONAL ALLERGY 17 0.0012
431 FAECES DISCOLOURED 26 0.0012
432 SINUS TACHYCARDIA 17 0.0012
433 HAIR TEXTURE ABNORMAL 16 0.0012
434 INCREASED TENDENCY TO BRUISE 11 0.0012
435 APHASIA 36 0.0012
436 PROCEDURAL PAIN 33 0.0012
437 EMPHYSEMA 12 0.0012
438 BLOOD PRESSURE DECREASED 79 0.0012
439 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
440 SINUS CONGESTION 16 0.0012
441 BACTERAEMIA 14 0.0012
442 HAEMOGLOBIN DECREASED 121 0.0012
443 VITAMIN D DECREASED 10 0.0012
444 DYSPNOEA EXERTIONAL 44 0.0012
445 SKIN HYPERPIGMENTATION 10 0.0012
446 POOR QUALITY SLEEP 25 0.0012
447 GASTROINTESTINAL HAEMORRHAGE 97 0.0012
448 TACHYCARDIA 103 0.0012
449 RENAL DISORDER 54 0.0012
450 BLOOD CALCIUM DECREASED 13 0.0012
451 TRANSFUSION 12 0.0011
452 NECK PAIN 64 0.0011
453 HYPERCHOLESTEROLAEMIA 11 0.0011
454 GRIP STRENGTH DECREASED 10 0.0011
455 FURUNCLE 9 0.0011
456 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
457 SKIN LESION 31 0.0011
458 SEPSIS 126 0.0011
459 HEPATIC STEATOSIS 21 0.0011
460 RHABDOMYOLYSIS 47 0.0011
461 BLOOD DISORDER 9 0.0011
462 WRONG DRUG ADMINISTERED 10 0.0011
463 THIRST 20 0.0011
464 QUALITY OF LIFE DECREASED 15 0.0011
465 MYOSITIS 10 0.0011
466 ANAEMIA 212 0.0011
467 HEAVY MENSTRUAL BLEEDING 10 0.0011
468 MUSCLE DISORDER 9 0.0011
469 HEAD INJURY 35 0.0011
470 COMPLICATION OF DEVICE INSERTION 22 0.0011
471 UPPER RESPIRATORY TRACT INFECTION 51 0.0011
472 BLOOD GLUCOSE DECREASED 53 0.0011
473 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
474 ACUTE HEPATIC FAILURE 15 0.0011
475 BONE DISORDER 20 0.0011
476 ATRIAL FIBRILLATION 106 0.0011
477 DRUG WITHDRAWAL SYNDROME NEONATAL 16 0.0011
478 EAR PAIN 21 0.0011
479 DEHYDRATION 144 0.0011
480 HEPATIC ENCEPHALOPATHY 10 0.0011
481 DEFORMITY 10 0.0011
482 PRESYNCOPE 26 0.0011
483 OXYGEN SATURATION DECREASED 60 0.0011
484 EYE DISCHARGE 11 0.0011
485 FACIAL PARALYSIS 9 0.0011
486 PETECHIAE 11 0.0011
487 SCAR 18 0.0011
488 INTERNAL HAEMORRHAGE 12 0.0010
489 NEOPLASM 12 0.0010
490 HYPERGLYCAEMIA 38 0.0010
491 MUSCLE SPASMS 191 0.0010
492 NASAL CONGESTION 61 0.0010
493 DRY MOUTH 84 0.0010
494 DYSKINESIA 42 0.0010
495 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
496 TOXICITY TO VARIOUS AGENTS 174 0.0010
497 GLYCOSYLATED HAEMOGLOBIN INCREASED 26 0.0010
498 EPISTAXIS 77 0.0010
499 CARDIO-RESPIRATORY ARREST 43 0.0010
500 EOSINOPHILIA 18 0.0010
501 HIP FRACTURE 33 0.0010
502 HAEMORRHOIDS 20 0.0010
503 GROIN PAIN 9 0.0010
504 UNEVALUABLE EVENT 77 0.0010
505 THERAPY CHANGE 10 0.0010
506 MYOCARDIAL INFARCTION 177 0.0010
507 CELLULITIS 51 0.0010
508 MUSCULAR WEAKNESS 115 0.0010
509 BACK INJURY 11 0.0010
510 FACIAL PAIN 9 0.0010
511 HALLUCINATION, AUDITORY 16 0.0010
512 PLATELET COUNT DECREASED 107 0.0010
513 FOOT FRACTURE 19 0.0010
514 OVARIAN CYST 10 0.0010
515 FEELING JITTERY 19 0.0010
516 HALLUCINATION, VISUAL 21 0.0010
517 WHITE BLOOD CELL COUNT INCREASED 38 0.0010
518 STEVENS-JOHNSON SYNDROME 22 0.0010
519 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
520 NOCTURIA 12 0.0010
521 OSTEOPENIA 15 0.0010
522 FEEDING DISORDER 20 0.0010
523 PRODUCT USE ISSUE 185 0.0010
524 NO THERAPEUTIC RESPONSE 12 0.0010
525 ABDOMINAL DISCOMFORT 165 0.0010
526 DRUG LEVEL DECREASED 10 0.0010
527 ORAL PAIN 22 0.0010
528 EMOTIONAL DISTRESS 118 0.0010
529 ANGIOEDEMA 43 0.0010
530 SYNCOPE 97 0.0010
531 JOINT RANGE OF MOTION DECREASED 13 0.0010
532 HAEMOPTYSIS 27 0.0010
533 LOSS OF CONSCIOUSNESS 124 0.0010
534 MYOCARDIAL ISCHAEMIA 11 0.0010
535 ANXIETY 275 0.0010
536 SEPTIC SHOCK 42 0.0010
537 SCAB 11 0.0010
538 MIDDLE INSOMNIA 18 0.0010
539 VIRAL INFECTION 32 0.0010
540 SWOLLEN TONGUE 30 0.0010
541 GAIT INABILITY 32 0.0010
542 SKIN DISCOLOURATION 44 0.0010
543 UNINTENDED PREGNANCY 10 0.0010
544 MENTAL IMPAIRMENT 23 0.0009
545 ELECTROLYTE IMBALANCE 11 0.0009
546 VASCULITIS 11 0.0009
547 PROSTATIC SPECIFIC ANTIGEN INCREASED 13 0.0009
548 ORAL DISCOMFORT 13 0.0009
549 DRUG RESISTANCE 24 0.0009
550 CHEST PAIN 173 0.0009
551 URINARY TRACT INFECTION 159 0.0009
552 CHROMATURIA 21 0.0009
553 HIATUS HERNIA 12 0.0009
554 SEIZURE 107 0.0009
555 DECREASED APPETITE 215 0.0009
556 HYPONATRAEMIA 52 0.0009
557 SKIN REACTION 13 0.0009
558 DIABETIC KETOACIDOSIS 22 0.0009
559 LIGAMENT SPRAIN 9 0.0009
560 LOCALISED INFECTION 22 0.0009
561 INJECTION SITE NODULE 10 0.0009
562 EMBEDDED DEVICE 9 0.0009
563 DRUG LEVEL INCREASED 15 0.0009
564 UPPER LIMB FRACTURE 18 0.0009
565 OSTEOPOROSIS 37 0.0009
566 NERVE INJURY 10 0.0009
567 CONSTIPATION 196 0.0009
568 CYTOPENIA 11 0.0009
569 MUSCULOSKELETAL PAIN 47 0.0009
570 ISCHAEMIC STROKE 16 0.0009
571 LACRIMATION INCREASED 27 0.0009
572 TYPE 2 DIABETES MELLITUS 30 0.0009
573 DEPRESSION 202 0.0009
574 REBOUND EFFECT 10 0.0009
575 BODY TEMPERATURE INCREASED 18 0.0009
576 RHINORRHOEA 57 0.0009
577 DYSPNOEA 499 0.0009
578 WEIGHT DECREASED 246 0.0009
579 SCIATICA 14 0.0009
580 BACK PAIN 204 0.0009
581 HAEMATURIA 30 0.0009
582 THROMBOSIS 70 0.0009
583 ABDOMINAL PAIN LOWER 22 0.0009
584 THERAPEUTIC RESPONSE UNEXPECTED 39 0.0009
585 URINARY RETENTION 29 0.0009
586 CARDIOVASCULAR DISORDER 22 0.0009
587 KIDNEY INFECTION 17 0.0009
588 BLOOD GLUCOSE ABNORMAL 16 0.0009
589 MUSCLE TIGHTNESS 14 0.0009
590 EYE SWELLING 32 0.0009
591 PNEUMONIA 278 0.0009
592 FALL 285 0.0009
593 SWELLING 80 0.0009
594 INFUSION SITE PAIN 11 0.0009
595 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
596 LETHARGY 49 0.0009
597 DEVICE DISLOCATION 37 0.0009
598 DRUG DISPENSING ERROR 13 0.0008
599 INSURANCE ISSUE 13 0.0008
600 OSTEOARTHRITIS 36 0.0008
601 ASTHENIA 319 0.0008
602 PALLOR 23 0.0008
603 URINARY INCONTINENCE 25 0.0008
604 BURNING SENSATION 59 0.0008
605 RED BLOOD CELL COUNT DECREASED 24 0.0008
606 LIVER FUNCTION TEST INCREASED 18 0.0008
607 SUBDURAL HAEMATOMA 12 0.0008
608 IMPAIRED QUALITY OF LIFE 12 0.0008
609 POST PROCEDURAL COMPLICATION 16 0.0008
610 BALANCE DISORDER 72 0.0008
611 DIVERTICULITIS 23 0.0008
612 VAGINAL HAEMORRHAGE 36 0.0008
613 OFF LABEL USE 726 0.0008
614 TOOTHACHE 15 0.0008
615 OSTEOMYELITIS 15 0.0008
616 HEADACHE 519 0.0008
617 PRODUCT DISPENSING ERROR 18 0.0008
618 PELVIC PAIN 15 0.0008
619 ASPIRATION 9 0.0008
620 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 45 0.0008
621 TOOTH LOSS 17 0.0008
622 CONFUSIONAL STATE 132 0.0008
623 CYSTITIS 26 0.0008
624 IRRITABILITY 49 0.0008
625 LABORATORY TEST ABNORMAL 24 0.0008
626 JOINT SWELLING 98 0.0008
627 CARDIAC FAILURE 65 0.0008
628 SKIN DISORDER 27 0.0008
629 HYPOAESTHESIA 121 0.0008
630 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
631 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
632 GINGIVAL BLEEDING 11 0.0008
633 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
634 COLON CANCER 12 0.0008
635 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 42 0.0008
636 DRUG INEFFECTIVE 1060 0.0008
637 LOCAL SWELLING 14 0.0008
638 PERIPHERAL COLDNESS 11 0.0008
639 DIABETES MELLITUS 61 0.0008
640 RESPIRATORY ARREST 22 0.0008
641 FATIGUE 616 0.0008
642 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
643 DIZZINESS 394 0.0008
644 HUNGER 11 0.0008
645 DERMATITIS CONTACT 9 0.0008
646 MICTURITION URGENCY 9 0.0008
647 DEEP VEIN THROMBOSIS 51 0.0008
648 LIP SWELLING 26 0.0008
649 LOWER LIMB FRACTURE 15 0.0008
650 PHARYNGEAL OEDEMA 12 0.0008
651 FLATULENCE 44 0.0008
652 NASOPHARYNGITIS 143 0.0008
653 ABDOMINAL PAIN 180 0.0008
654 SKIN ULCER 20 0.0008
655 CHEST DISCOMFORT 79 0.0008
656 BRONCHOSPASM 11 0.0008
657 BRONCHITIS 57 0.0008
658 RESTLESS LEGS SYNDROME 14 0.0008
659 BONE PAIN 45 0.0008
660 NEUROPATHY PERIPHERAL 73 0.0008
661 PLATELET COUNT INCREASED 10 0.0008
662 BRAIN FOG 12 0.0008
663 VISION BLURRED 105 0.0008
664 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
665 CIRCULATORY COLLAPSE 13 0.0008
666 COUGH 214 0.0008
667 AGITATION 56 0.0008
668 JOINT STIFFNESS 20 0.0008
669 CHOLELITHIASIS 25 0.0008
670 AGEUSIA 19 0.0008
671 ANOSMIA 11 0.0008
672 ORAL CANDIDIASIS 10 0.0008
673 DYSPHAGIA 72 0.0008
674 SNEEZING 17 0.0008
675 HYPOKINESIA 11 0.0008
676 GAIT DISTURBANCE 145 0.0008
677 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
678 PANCREATITIS ACUTE 17 0.0008
679 HOT FLUSH 57 0.0008
680 COMA 36 0.0008
681 CONJUNCTIVITIS 14 0.0008
682 ULCER 12 0.0008
683 DYSMENORRHOEA 10 0.0008
684 ABSCESS 12 0.0008
685 PALPITATIONS 88 0.0008
686 CONDITION AGGRAVATED 228 0.0007
687 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
688 HEPATIC ENZYME INCREASED 51 0.0007
689 MALIGNANT MELANOMA 10 0.0007
690 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
691 FULL BLOOD COUNT DECREASED 15 0.0007
692 SKIN HAEMORRHAGE 11 0.0007
693 THERAPEUTIC RESPONSE DECREASED 45 0.0007
694 DIARRHOEA 478 0.0007
695 DEVICE EXPULSION 48 0.0007
696 PANCREATITIS 39 0.0007
697 BLOOD URINE PRESENT 14 0.0007
698 RASH GENERALISED 19 0.0007
699 PANCYTOPENIA 41 0.0007
700 DYSPEPSIA 72 0.0007
701 HYPERHIDROSIS 94 0.0007
702 PAIN 447 0.0007
703 OSTEONECROSIS OF JAW 18 0.0007
704 SPEECH DISORDER 38 0.0007
705 CYST 9 0.0007
706 DRY EYE 36 0.0007
707 HYPOACUSIS 31 0.0007
708 POLLAKIURIA 30 0.0007
709 MUSCULOSKELETAL STIFFNESS 63 0.0007
710 ABDOMINAL DISTENSION 75 0.0007
711 COVID-19 126 0.0007
712 PLASMA CELL MYELOMA 28 0.0007
713 COORDINATION ABNORMAL 10 0.0007
714 HEART RATE INCREASED 71 0.0007
715 GLOSSODYNIA 16 0.0007
716 DYSGEUSIA 53 0.0007
717 LYMPHOMA 11 0.0007
718 RASH ERYTHEMATOUS 34 0.0007
719 PRODUCT USE IN UNAPPROVED INDICATION 176 0.0007
720 HAEMATEMESIS 18 0.0007
721 WHEEZING 42 0.0007
722 LUNG INFECTION 11 0.0007
723 THROMBOCYTOPENIA 79 0.0007
724 THERAPY PARTIAL RESPONDER 11 0.0007
725 RETCHING 15 0.0007
726 HALLUCINATION 53 0.0007
727 THERAPY CESSATION 36 0.0007
728 NAUSEA 555 0.0007
729 ERECTILE DYSFUNCTION 18 0.0007
730 VOMITING 329 0.0007
731 AGRANULOCYTOSIS 13 0.0007
732 NEURALGIA 17 0.0007
733 PARALYSIS 10 0.0007
734 RECTAL HAEMORRHAGE 30 0.0007
735 CYTOKINE RELEASE SYNDROME 14 0.0007
736 HYPERSOMNIA 20 0.0007
737 MUSCULOSKELETAL DISCOMFORT 12 0.0007
738 SHOCK 16 0.0007
739 PNEUMOTHORAX 11 0.0007
740 TREMOR 115 0.0007
741 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
742 GASTRIC ULCER 13 0.0007
743 RESTLESSNESS 25 0.0007
744 FEELING COLD 19 0.0007
745 CHILLS 80 0.0007
746 DISORIENTATION 27 0.0007
747 RIB FRACTURE 14 0.0007
748 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
749 GLAUCOMA 13 0.0007
750 HERNIA 13 0.0007
751 ABDOMINAL PAIN UPPER 138 0.0007
752 BLOOD GLUCOSE INCREASED 126 0.0007
753 PAIN OF SKIN 18 0.0007
754 HYPOPHAGIA 17 0.0007
755 COMPLICATION OF DEVICE REMOVAL 12 0.0007
756 INTESTINAL OBSTRUCTION 25 0.0007
757 DRUG EFFECT INCOMPLETE 24 0.0007
758 SWELLING FACE 43 0.0007
759 LEUKOPENIA 33 0.0007
760 EATING DISORDER 14 0.0007
761 EYE PAIN 37 0.0007
762 ARRHYTHMIA 31 0.0007
763 IRRITABLE BOWEL SYNDROME 14 0.0007
764 CARDIAC DISORDER 61 0.0007
765 SLEEP DISORDER 46 0.0007
766 PAIN IN EXTREMITY 192 0.0007
767 DEAFNESS 17 0.0006
768 HEMIPARESIS 11 0.0006
769 THYROID DISORDER 10 0.0006
770 SURGERY 38 0.0006
771 PRURITUS GENERALISED 14 0.0006
772 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
773 BACTERIAL INFECTION 12 0.0006
774 BLOOD TEST ABNORMAL 9 0.0006
775 IMPAIRED HEALING 21 0.0006
776 CATARACT 38 0.0006
777 WHITE BLOOD CELL COUNT DECREASED 69 0.0006
778 CYANOSIS 10 0.0006
779 SINUSITIS 65 0.0006
780 PULMONARY EMBOLISM 60 0.0006
781 DISEASE RECURRENCE 30 0.0006
782 MUSCULOSKELETAL DISORDER 12 0.0006
783 BLOOD BILIRUBIN INCREASED 17 0.0006
784 RASH MACULAR 22 0.0006
785 PRODUCT DOSE OMISSION 41 0.0006
786 INCREASED APPETITE 12 0.0006
787 INSOMNIA 167 0.0006
788 EYE IRRITATION 36 0.0006
789 COLD SWEAT 11 0.0006
790 MOOD ALTERED 17 0.0006
791 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
792 LYMPHOCYTE COUNT DECREASED 11 0.0006
793 WEIGHT INCREASED 139 0.0006
794 NIGHT SWEATS 20 0.0006
795 MYALGIA 105 0.0006
796 SOMNOLENCE 124 0.0006
797 ABNORMAL DREAMS 17 0.0006
798 MUCOSAL INFLAMMATION 16 0.0006
799 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 110 0.0006
800 NERVOUS SYSTEM DISORDER 19 0.0006
801 JOINT INJURY 13 0.0006
802 MUSCLE TWITCHING 14 0.0006
803 DISABILITY 12 0.0006
804 RESPIRATORY DISORDER 18 0.0006
805 BLOOD CHOLESTEROL INCREASED 28 0.0006
806 DRUG INTOLERANCE 58 0.0006
807 BONE LOSS 9 0.0006
808 DYSURIA 22 0.0006
809 ANGINA PECTORIS 17 0.0006
810 MALAISE 260 0.0006
811 DISCOMFORT 36 0.0006
812 LIMB INJURY 16 0.0006
813 FEELING HOT 36 0.0006
814 PHOTOPHOBIA 11 0.0006
815 DYSSTASIA 17 0.0006
816 LIMB DISCOMFORT 18 0.0006
817 DYSPHONIA 34 0.0006
818 VISUAL IMPAIRMENT 72 0.0006
819 HAEMATOCHEZIA 32 0.0006
820 EJECTION FRACTION DECREASED 9 0.0006
821 PARAESTHESIA 91 0.0006
822 ARTHRALGIA 240 0.0006
823 STOMATITIS 35 0.0006
824 BONE DENSITY DECREASED 18 0.0006
825 HAEMORRHAGE 60 0.0006
826 CHOLESTASIS 11 0.0006
827 FEELING ABNORMAL 137 0.0006
828 RASH 249 0.0006
829 FUNGAL INFECTION 19 0.0006
830 GASTRITIS 15 0.0006
831 PRURITUS 218 0.0006
832 HYPOTHYROIDISM 18 0.0006
833 PYREXIA 195 0.0006
834 ILLNESS 58 0.0006
835 SKIN FISSURES 11 0.0006
836 THERAPY INTERRUPTED 40 0.0006
837 SKIN CANCER 12 0.0006
838 PRODUCT DOSE OMISSION ISSUE 162 0.0006
839 HYPERSENSITIVITY 102 0.0005
840 ASTHMA 62 0.0005
841 MANIA 9 0.0005
842 ARTHRITIS 43 0.0005
843 MEMORY IMPAIRMENT 75 0.0005
844 SKIN EXFOLIATION 46 0.0005
845 PRODUCT ADMINISTRATION ERROR 11 0.0005
846 HOSPITALISATION 83 0.0005
847 NERVOUSNESS 28 0.0005
848 THROAT IRRITATION 24 0.0005
849 SEDATION 14 0.0005
850 INTENTIONAL OVERDOSE 34 0.0005
851 ALOPECIA 104 0.0005
852 MOVEMENT DISORDER 17 0.0005
853 DERMATITIS 11 0.0005
854 CONVULSION 30 0.0005
855 PRODUCTIVE COUGH 25 0.0005
856 KNEE ARTHROPLASTY 11 0.0005
857 TINNITUS 24 0.0005
858 HERPES ZOSTER 30 0.0005
859 DRUG ADMINISTRATION ERROR 16 0.0005
860 PNEUMONIA ASPIRATION 13 0.0005
861 ACCIDENTAL OVERDOSE 19 0.0005
862 DEVICE BREAKAGE 21 0.0005
863 BLISTER 29 0.0005
864 METASTASES TO LIVER 9 0.0005
865 FLUSHING 52 0.0005
866 LUNG DISORDER 25 0.0005
867 LYMPHADENOPATHY 18 0.0005
868 EYE PRURITUS 17 0.0005
869 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
870 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 102 0.0005
871 GASTROINTESTINAL DISORDER 45 0.0005
872 WOUND 14 0.0005
873 SPINAL FRACTURE 10 0.0005
874 INFECTION 72 0.0005
875 PRODUCT PHYSICAL ISSUE 10 0.0005
876 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
877 PAIN IN JAW 14 0.0005
878 DERMATITIS ATOPIC 26 0.0005
879 DRUG ABUSE 41 0.0005
880 VERTIGO 30 0.0005
881 RASH PAPULAR 11 0.0005
882 ANAPHYLACTIC REACTION 27 0.0005
883 ERYTHEMA 100 0.0005
884 ABASIA 12 0.0005
885 LIVER FUNCTION TEST ABNORMAL 14 0.0005
886 RASH PRURITIC 26 0.0005
887 ROAD TRAFFIC ACCIDENT 20 0.0005
888 NEUTROPENIA 65 0.0005
889 ASCITES 14 0.0005
890 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
891 BLINDNESS 19 0.0005
892 OROPHARYNGEAL PAIN 43 0.0005
893 NIGHTMARE 16 0.0005
894 DELIRIUM 16 0.0005
895 MENTAL DISORDER 20 0.0005
896 MALIGNANT NEOPLASM PROGRESSION 47 0.0005
897 MENORRHAGIA 9 0.0005
898 DRY SKIN 61 0.0005
899 WITHDRAWAL SYNDROME 19 0.0005
900 FEBRILE NEUTROPENIA 30 0.0005
901 FEMUR FRACTURE 14 0.0005
902 PRODUCT SUBSTITUTION ISSUE 26 0.0005
903 ARTHROPATHY 25 0.0004
904 INFLUENZA LIKE ILLNESS 37 0.0004
905 INFLUENZA 50 0.0004
906 DISEASE PROGRESSION 53 0.0004
907 TREATMENT FAILURE 37 0.0004
908 INTENTIONAL PRODUCT MISUSE 39 0.0004
909 ADVERSE DRUG REACTION 40 0.0004
910 DEATH 383 0.0004
911 THROAT TIGHTNESS 12 0.0004
912 OCULAR HYPERAEMIA 21 0.0004
913 URTICARIA 73 0.0004
914 DRUG DOSE OMISSION 72 0.0004
915 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
916 DIPLOPIA 11 0.0004
917 RHEUMATOID ARTHRITIS 48 0.0004
918 COLITIS 16 0.0004
919 IMPAIRED WORK ABILITY 9 0.0004
920 MIGRAINE 40 0.0004
921 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
922 EAR INFECTION 11 0.0004
923 PANIC ATTACK 15 0.0004
924 MELAENA 9 0.0004
925 JAUNDICE 11 0.0004
926 INFUSION RELATED REACTION 27 0.0004
927 PRODUCT QUALITY ISSUE 55 0.0004
928 PNEUMONITIS 11 0.0004
929 HEART RATE IRREGULAR 9 0.0004
930 HEPATIC FAILURE 12 0.0004
931 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
932 EYE DISORDER 13 0.0004
933 HEPATITIS 10 0.0004
934 INJECTION SITE PRURITUS 26 0.0004
935 INTENTIONAL DOSE OMISSION 11 0.0004
936 CRYING 14 0.0004
937 RESPIRATORY TRACT INFECTION 10 0.0004
938 PSORIASIS 50 0.0004
939 ECZEMA 20 0.0004
940 PANCREATIC CARCINOMA 11 0.0004
941 NO ADVERSE EVENT 69 0.0004
942 INJECTION SITE MASS 14 0.0004
943 NEOPLASM PROGRESSION 13 0.0004
944 SUICIDAL IDEATION 34 0.0004
945 DRUG EFFECT DECREASED 20 0.0004
946 PSORIATIC ARTHROPATHY 15 0.0004
947 INFLAMMATION 19 0.0004
948 LIVER DISORDER 16 0.0004
949 DEMENTIA 10 0.0004
950 ANGER 12 0.0004
951 INCORRECT DOSE ADMINISTERED 81 0.0004
952 TARDIVE DYSKINESIA 10 0.0004
953 EXTRA DOSE ADMINISTERED 14 0.0003
954 UNDERDOSE 25 0.0003
955 DEVICE MALFUNCTION 24 0.0003
956 AGGRESSION 17 0.0003
957 LACTIC ACIDOSIS 11 0.0003
958 OVERDOSE 73 0.0003
959 OSTEONECROSIS 11 0.0003
960 MYELOSUPPRESSION 12 0.0003
961 INJECTION SITE PAIN 102 0.0003
962 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
963 C-REACTIVE PROTEIN INCREASED 12 0.0003
964 INJECTION SITE SWELLING 25 0.0003
965 LUNG NEOPLASM MALIGNANT 13 0.0003
966 MULTIPLE SCLEROSIS 15 0.0003
967 COLITIS ULCERATIVE 14 0.0003
968 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
969 PRODUCT ADHESION ISSUE 11 0.0003
970 ABNORMAL BEHAVIOUR 12 0.0003
971 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
972 EXPIRED PRODUCT ADMINISTERED 10 0.0003
973 DISTURBANCE IN ATTENTION 16 0.0003
974 ADVERSE EVENT 27 0.0003
975 ILL-DEFINED DISORDER 17 0.0003
976 DEVICE ISSUE 25 0.0003
977 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
978 INJECTION SITE HAEMORRHAGE 22 0.0003
979 HEPATIC FUNCTION ABNORMAL 10 0.0003
980 INJECTION SITE BRUISING 21 0.0003
981 INTERSTITIAL LUNG DISEASE 12 0.0002
982 SKIN IRRITATION 11 0.0002
983 NEOPLASM MALIGNANT 16 0.0002
984 DRUG WITHDRAWAL SYNDROME 20 0.0002
985 INJECTION SITE ERYTHEMA 28 0.0002
986 ACNE 17 0.0002
987 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
988 SKIN BURNING SENSATION 14 0.0002
989 DEVICE DIFFICULT TO USE 12 0.0002
990 PROSTATE CANCER 13 0.0002
991 BREAST CANCER 15 0.0002
992 INJECTION SITE REACTION 10 0.0001
993 PRODUCT STORAGE ERROR 12 0.0001
994 DRUG DEPENDENCE 11 0.0001